Dr. Erin Mary Bange, MD

Dr. Bange practices at Memorial Sloan Kettering Basking Ridge in Basking Ridge, New Jersey.

Dr. Bange's NPI, 1891157566, was assigned on March 22, 2016. Dr. Bange graduated from Sidney Kimmel Medical College in 2016. Dr. Bange holds Pennsylvania license MD464665.

Dr. Bange's primary practice is Memorial Sloan Kettering Basking Ridge, at 136 Mountainview Blvd, Basking Ridge, NJ 07920 in Somerset County. The practice phone is (908) 542-3000.

Dr. Bange's primary practice is Memorial Sloan Kettering Basking Ridge in Basking Ridge, New Jersey. Dr. Bange is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Memorial Sloan Kettering Cancer Center at Basking Ridge New Jersey. Dmand AI also links Dr. Bange to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bange practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bange's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bange is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bange's licenses on file in 5 states: Pennsylvania, Florida, Connecticut, New Jersey and New York.

Dmand AI lists prostate cancer among the conditions Dr. Bange treats.

CMS data shows 262 Medicare services from Dr. Bange across 4 procedure codes in 2024, all of them office visits, for 116 Medicare patients. Medicare paid $24,342 for them. Every service was in an office.

CMS counts 116 Medicare patients who saw Dr. Bange in 2024. The largest group is 75 to 84, with 53 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bange's median patient age at 75, with 10% women.

In 2024, Dr. Bange wrote 512 Medicare Part D claims for 83 patients. 77% of them were for generic drugs. CMS names the drug for 427 of them, across 8 drugs with 11 or more claims each, at $926,674 in total drug cost. In 2023, CMS named 398 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Bange for performance year 2024, reported as part of a group. Dr. Bange accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bange as offering telehealth.

Dmand AI links 20 papers to Dr. Bange, published from 2018 to 2025. 2021 was the busiest year, with 5. The most frequent topics are COVID-19, SARS-CoV-2 and Pandemics. Dr. Bange has published most often in JCO Oncol Pract. Dr. Bange's most frequent co-authors are Ronac Mamtani, MD, Michael Morris, MD and Peter David Stetson, MD.

CMS Open Payments shows 5 general payments to Dr. Bange from 1 drug or device company in 2017. Education make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $100.

Dr. Bange graduated from Sidney Kimmel Medical College in 2016.

Dr. Bange is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.